학술논문

Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 study
Document Type
Article
Source
In The Lancet Oncology October 2019 20(10):1386-1394
Subject
Primary Research
Articles
Language
ISSN
1470-2045